An AllTrials project

NCT03688685: A reported trial by Cadent Therapeutics

This trial has reported on time, in line with the regulations.

Full data

Full entry on ClinicalTrials.gov NCT03688685
Title A Phase 2a Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of CAD-1883 Oral Treatment in Adults With Essential Tremor
Results Status Reported
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date Jan. 23, 2019
Completion date Sept. 10, 2019
Required reporting date Sept. 10, 2022, midnight
Actual reporting date June 18, 2021
Date last checked at ClinicalTrials.gov Feb. 9, 2024
Days late None